Low dose ketamine for sickle cell pain crisis
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests if a low dose of ketamine can help relieve pain for people with sickle cell disease who come to the emergency room with a pain crisis. It aims to find a better way to manage pain during these episodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sickle cell disease (any type)
- You are in the emergency room with a pain crisis
- You are not allergic to ketamine
- You are not pregnant
- You have not used ketamine in the last 24 hours
- Your pain is not from another urgent problem like fever or chest pain
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a low-dose of ketamine (a pain medicine) can help children and young adults with sickle cell disease who are in a pain crisis. It aims to provide better pain relief while avoiding some side effects of standard painkillers.
This trial tests if adding lidocaine to standard pain treatment can reduce the amount of morphine or oxycodone needed for a severe pain crisis or acute chest syndrome in sickle cell disease. It is for adults in the ICU who have already started opioid treatment within the last 72 hours.
This trial tests whether using a virtual reality (VR) headset, along with your usual pain treatment, can help reduce pain during a sickle cell crisis. It is for adults with sickle cell disease who are in the emergency department and receiving IV opioids for a vaso-occlusive crisis.
This trial tests whether taking ketamine by mouth can help treat “vaso-occlusive” pain episodes that may require hospital admission. If it works, it could offer an easier way to manage severe pain during sickle cell crises.
This trial tests when to start ketamine for children and teens with sickle cell disease who are in pain. It aims to find the best timing to help reduce pain in the emergency room or infusion clinic.
This trial tests a fentanyl-like nose spray (sufentanil) to relieve severe pain from a sickle cell crisis in children and teens. It aims to see if it works better than usual pain treatments.
Hear when a new Vaso-Occlusive Pain Episode in Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.